NEWS
Our Latest News
ARCHIMED MedTech sells orthopedic implants maker Citieffe to Poly Medicure, a leading global manufacturer of medical devices
Citieffe was the last investment in ARCHIMED’s MED I fund, now fully liquidated after generating 7.2 times investors’ money, or a 59 percent annual return over 11 years – the best performance of any 2014-vintage buyout fund.
ARCHIMED’s Direct Healthcare Group sees annual revenue more than double through four Buy-and-Build purchases over nine months
January
25,
2021
ARCHIMED’s BOMI Group enters new geographies and market segments through six Buy-and-Build acquisitions made over eight months
January
25,
2021
ARCHIMED buys Germany’s Zyto Group of Cancer Diagnostics companies in partnership with owners and management
January
12,
2021
ARCHIMED’s NAMSA announces key acquisition of Syntactx
January
5,
2021
368